1. Home
  2. GLYC vs LOBO Comparison

GLYC vs LOBO Comparison

Compare GLYC & LOBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLYC
  • LOBO
  • Stock Information
  • Founded
  • GLYC 2003
  • LOBO 2014
  • Country
  • GLYC United States
  • LOBO China
  • Employees
  • GLYC N/A
  • LOBO N/A
  • Industry
  • GLYC Biotechnology: Pharmaceutical Preparations
  • LOBO
  • Sector
  • GLYC Health Care
  • LOBO
  • Exchange
  • GLYC Nasdaq
  • LOBO NYSE
  • Market Cap
  • GLYC 16.2M
  • LOBO 13.6M
  • IPO Year
  • GLYC 2014
  • LOBO 2024
  • Fundamental
  • Price
  • GLYC $0.24
  • LOBO $0.74
  • Analyst Decision
  • GLYC Hold
  • LOBO
  • Analyst Count
  • GLYC 3
  • LOBO 0
  • Target Price
  • GLYC N/A
  • LOBO N/A
  • AVG Volume (30 Days)
  • GLYC 470.6K
  • LOBO 106.5K
  • Earning Date
  • GLYC 05-16-2025
  • LOBO 04-29-2025
  • Dividend Yield
  • GLYC N/A
  • LOBO N/A
  • EPS Growth
  • GLYC N/A
  • LOBO N/A
  • EPS
  • GLYC N/A
  • LOBO N/A
  • Revenue
  • GLYC N/A
  • LOBO $21,188,606.00
  • Revenue This Year
  • GLYC N/A
  • LOBO $77.34
  • Revenue Next Year
  • GLYC N/A
  • LOBO N/A
  • P/E Ratio
  • GLYC N/A
  • LOBO N/A
  • Revenue Growth
  • GLYC N/A
  • LOBO 36.92
  • 52 Week Low
  • GLYC $0.14
  • LOBO $0.46
  • 52 Week High
  • GLYC $1.93
  • LOBO $3.52
  • Technical
  • Relative Strength Index (RSI)
  • GLYC 51.12
  • LOBO N/A
  • Support Level
  • GLYC $0.23
  • LOBO N/A
  • Resistance Level
  • GLYC $0.29
  • LOBO N/A
  • Average True Range (ATR)
  • GLYC 0.02
  • LOBO 0.00
  • MACD
  • GLYC 0.00
  • LOBO 0.00
  • Stochastic Oscillator
  • GLYC 40.63
  • LOBO 0.00

About GLYC GlycoMimetics Inc.

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

About LOBO LOBO EV TECHNOLOGIES LTD

Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.

Share on Social Networks: